TG-873870 (Nemonoxacin)
TG-873870-04
Phase 2 small_molecule completed
Quick answer
TG-873870 (Nemonoxacin) for Diabetic Foot Infections is a Phase 2 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Diabetic Foot Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed